| For: | Bharaj IS, Brar AS, Kahlon J, Singh A, Hotwani P, Kumar V, Sohal A, Batta A. Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis. World J Cardiol 2025; 17(6): 106147 [PMID: 40575425 DOI: 10.4330/wjc.v17.i6.106147] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v17/i6/106147.htm |
| Number | Citing Articles |
| 1 |
Inderjeet Singh Bharaj, Ajit Brar, Aayushi Kacheria, Karen Purewal, Austin Simister, Umabalan Thirupathy, Palak Gupta, Jasraj Kahlon, Juzer Munaim, Ei Ei Thwe, Samer Ibrahim, Valerie Martinez Vargas, Krishnaswami Vijayaraghavan. Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo. Biomedicines 2025; 13(9) doi: 10.3390/biomedicines13092192
|
| 2 |
Johannes Bauer, Sophie Gensluckner, Julian Eberhardt, Alexander Akhgar, Christian Datz, Bernhard Iglseder, Patrick Langthaler, Eugen Trinka, Mathias Ausserwinkler, Georg Semmler, Bernhard Paulweber, Elmar Aigner, Bernhard Wernly. Atherosclerosis burden across subtypes of steatotic liver disease: a European cohort analysis. Nutrition, Metabolism and Cardiovascular Diseases 2026; 36(6) doi: 10.1016/j.numecd.2026.104618
|
| 3 |
Lavinia Alice Bălăceanu, Cristiana Grigore, Beatrice Bălăceanu-Gurău, Cristian-Dorin Gurău, Ioana Valeria Grigorescu, Ion Dina. Paroxysmal Atrial Fibrillation in Liver Diseases: Epidemiology and Possible Pathophysiological Mechanisms. Journal of Clinical Medicine 2026; 15(3) doi: 10.3390/jcm15031156
|
| 4 |
Syed Sarmad Javaid, Umar Maqbool, Muhammad Ahmed Shaikh, Osama Ijaz, Sarah Musani, Zaland Ahmed Yousafzai, Amber Siddique, Noor Qanita Malik, Razeen Shafique, Seeme Rukh, Fatima Jawed, Faizan Ahmed, Hamza Bashir, Muhammad Adnan Kanpurwala, Ahmed Ali Aziz, Ashujot Kaur Dang, Muhammad Shikaib Shabbir. Assessing the impact of metabolic dysfunction-associated steatotic liver disease on clinical outcomes in patients with acute myocardial infarction: a national inpatient sample analysis (2018–2020). Future Cardiology 2026; 22(3) doi: 10.1080/14796678.2026.2633969
|
| 5 |
Nebyu Yonas Shanka, Chavdar S. Pavlov, Taisiia A. Turankova, Temesgen Tesfaye Ajabo, Leul Mekonnen Nigatu, Biniyam Esayas Dana, Poorani Gurumallesh Prabu. Predicting Clinically Significant Portal Hypertension in MASLD Using Routine Ultrasound and Clinical Data: A Retrospective Cohort Study. BioMed Research International 2026; 2026(1) doi: 10.1155/bmri/1662756
|
| 6 |
Asad Ali Ahmed Cheema, Sadaf Siddiqui, Syed Ali Waheed, Izzah Hassan Samra, Safia Memon, Jannat Yaqoob, Amna Rana, Maryam Mazhar, Hibba Tahir, Nurmeen Mushtaq, Fatima Mushtaq, Hafiz Muhammad Kashif Saleem. Trends in atrial fibrillation and non-alcoholic fatty liver disease-related mortality in the United States from 1999 to 2020: a CDC WONDER analysis. Annals of Medicine & Surgery 2026; 88(6) doi: 10.1097/MS9.0000000000005012
|
| 7 |
Agata Morawska, Rafał Frankowski, Mikołaj Grabarczyk, Marcin Kosmalski, Monika Różycka-Kosmalska. Crosstalk Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications. Life 2025; 15(11) doi: 10.3390/life15111713
|
| 8 |
Minhong Kim, Hyun-Ah Lee, Joungyoun Kim, Hee-Taik Kang. Metabolic dysfunction–associated steatotic liver disease and incident coronary events with revascularization: A nationwide cohort study. Atherosclerosis 2026; 415 doi: 10.1016/j.atherosclerosis.2026.120698
|
| 9 |
Luca Di Lullo, Aldo Franculli, Pasquale Saporito, Andrea Dello Strologo, Laura Pedata, Vincenzo Barbera, Lorenzo D’Elia, Antonio Bellasi, Paola Peverini. Anticoagulant strategies in atrial fibrillation and chronic kidney disease: From pathophysiology to clinical practice. Journal of Translational Critical Care Medicine 2026; 8(1) doi: 10.1097/JTCCM-D-23-00013
|
| 10 |
Akash Batta, Razieh Parizad, Juniali Hatwal, Ankur Mittal, Manjeet Kumar Goyal, Bishav Mohan. Frailty and advanced age in atrial fibrillation: Implications for treatment strategies and clinical outcomes – A systematic review. Indian Heart Journal 2026; doi: 10.1016/j.ihj.2026.04.006
|
| 11 |
Yao Zhang, JiaXin Qi, Xia Chen, Lin Pang, Zhangwei Shi, Bowen Wei, Cheng Lian. Atrial fibrillation identification in patients with non-alcoholic fatty liver disease: a machine learning model based on immune-inflammatory markers. Diabetology & Metabolic Syndrome 2025; 18(1) doi: 10.1186/s13098-025-02025-8
|
| 12 |
Wei Luo. A bidirectional relationship between atrial fibrillation and depression: epidemiology, mechanisms, and clinical implications. Frontiers in Psychiatry 2026; 17 doi: 10.3389/fpsyt.2026.1721875
|
| 13 |
Carlo Ratti, Mattia Malaguti, D'Aniello Emanuele, Antonio Bellasi, Gianluca Sanna. Understanding MASLD — from molecular pathogenesis to cardiovascular risk: A concise review for the clinical cardiologist. Atherosclerosis 2025; 409 doi: 10.1016/j.atherosclerosis.2025.120495
|
| 14 |
Tariq Alrasheed, Mohamed E. A. Mostafa, Mohammed A Madkhali, Hesham A Khairy. Inflammatory biomarker response to GLP-1 receptor agonists versus other glucose-lowering medications in patients with type 2 diabetes: a systematic review and meta-analysis. Frontiers in Endocrinology 2026; 16 doi: 10.3389/fendo.2025.1734549
|